The relationship between peptide structure and antibacterial activity

Peptides

Volumn 24, Issue 11, 2003, Pages 1681-1691

  Powers, Jon Paul S ^a   Hancock, Robert E W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antimicrobial cationic peptide; Polyphemusin; Structure

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BETA DEFENSIN; CIRCULIN; DEFENSIN; DROSOMYCIN; GOMISIN; HELIOMYCIN; HEPCIDIN; HEPCIDIN 20; HEPCIDIN 25; INDOLICIDIN; INDOLICIDIN DERIVATIVE; LACTOFERRICIN; LEUCOCIN A; MAGAININ 2; MEDITERRANEAN MUSSEL DEFENSIN; MEMBRANE LIPID; MORICIN; OVISPIRIN 1; PEPTIDE DERIVATIVE; PROTEGRIN; RAMOPLANIN; SAPECIN; TACHYSTATIN A; THANATIN; THETA DEFENSIN; THIONINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; BILAYER MEMBRANE; CONFORMATION; CRAB; DRUG MECHANISM; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IMMUNE RESPONSE; LIPID COMPOSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; RABBIT; REVIEW; STRUCTURE ACTIVITY RELATION; XENOPUS LAEVIS;

EID: 1042278915     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.08.023     Document Type: Article

References (102)

1. Aley S.B., Zimmerman M., Hetsko M., Selsted M.E., Gillin F.D. Killing of Giardia lamblia by cryptdins and cationic neutrophil peptides. Infect. Immun. 62:1994;5397-5403.
2. Almeida M.S., Cabral K.M., Kurtenbach E., Almeida F.C., Valente A.P. Solution structure of Pisum sativum defensin 1 by high resolution NMR: plant defensins, identical backbone with different mechanisms of action. J. Mol. Biol. 315:2002;749-757.
3. Baker M.A., Maloy W.L., Zasloff M., Jacob L.S. Anticancer efficacy of magainin 2 and analogue peptides. Cancer Res. 53:1993;3052-3057.
4. Bauer F., Schweimer K., Kluver E., Conejo-Garcia J.R., Forssmann W.G., Rosch P.et al. Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci. 10:2001;2470-2479.
5. Bessalle R., Kapitkovsky A., Gorea A., Shalit I., Fridkin M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett. 274:1990;151-155.
6. Bogdanov M., Sun J., Kaback H.R., Dowhan W. A phospholipid acts as a chaperone in assembly of a membrane transport protein. J. Biol. Chem. 271:1996;11615-11618.
7. Brotz H., Bierbaum G., Leopold K., Reynolds P.E., Sahl H.G. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II. Antimicrob. Agents Chemother. 42:1998;154-160.
8. 1H -NMR: a structural motif common to toxic arthropod proteins Biochemistry. 32:1993;715-724.
9. Cornet B., Bonmatin J.M., Hetru C., Hoffmann J.A., Ptak M., Vovelle F. Refined three-dimensional solution structure of insect defensin A. Structure. 3:1995;435-448.
10. Daly N.L., Koltay A., Gustafson K.R., Boyd M.R., Casas-Finet J.R., Craik D.J. Solution structure by NMR of circulin A: a macrocyclic knotted peptide having anti-HIV activity. J. Mol. Biol. 285:1999;333-345.
11. Dathe M., Nikolenko H., Meyer J., Beyermann M., Bienert M. Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett. 501:2001;146-150.
12. Ehrenstein G., Lecar H. Electrically gated ionic channels in lipid bilayers. Q. Rev. Biophys. 10:1977;1-34.
13. Epand R.M., Vogel H.J. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta. 1462:1999;11-28.
14. Fahrner R.L., Dieckmann T., Harwig S.S., Lehrer R.I., Eisenberg D., Feigon J. Solution structure of protegrin-1, a broad-spectrum antimicrobial peptide from porcine leukocytes. Chem. Biol. 3:1996;543-550.
15. Falla T.J., Karunaratne D.N., Hancock R.E.W. Mode of action of the antimicrobial peptide indolicidin. J. Biol. Chem. 271:1996;19298-19303.
16. 1H nuclear magnetic resonance Proteins. 37:1999;388-403.
17. Fehlbaum P., Bulet P., Chernysh S., Briand J.P., Roussel J.P., Letellier L.et al. Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1221-1225.
18. Fregeau Gallagher N.L., Sailer M., Niemczura W.P., Nakashima T.T., Stiles M.E., Vederas J.C. Three-dimensional structure of leucocin A in trifluoroethanol and dodecylphosphocholine micelles: spatial location of residues critical for biological activity in type IIa bacteriocins from lactic acid bacteria. Biochemistry. 36:1997;15062-15072.
19. Friedrich C., Scott M.G., Karunaratne N., Yan H., Hancock R.E.W. Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob. Agents Chemother. 43:1999;1542-1548.
20. Friedrich C.L., Moyles D., Beveridge T.J., Hancock R.E.W. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob. Agents Chemother. 44:2000;2086-2092.
21. Friedrich C.L., Rozek A., Patrzykat A., Hancock R.E.W. Structure and mechanism of action of an indolicidin peptide derivative with improved activity against Gram-positive bacteria. J. Biol. Chem. 276:2001;24015-24022.
22. Fujitani N., Kawabata Si S., Osaki T., Kumaki Y., Demura M., Nitta K.et al. Structure of the antimicrobial peptide tachystatin A. J. Biol. Chem. 16:2002;16.
23. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K.et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276:2001;5836-5840.
24. Gallo R.L., Ono M., Povsic T., Page C., Eriksson E., Klagsbrun M.et al. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. U.S.A. 91:1994;11035-11039.
25. Gao G.H., Liu W., Dai J.X., Wang J.F., Hu Z., Zhang Y.et al. Solution structure of PAFP-S: a new knottin-type antifungal peptide from the seeds of Phytolacca americana. Biochemistry. 40:2001;10973-10978.
26. 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution J. Biomol. NMR. 9:1997;127-135.
27. Giacometti A., Cirioni O., Barchiesi F., Del Prete M.S., Scalise G. Antimicrobial activity of polycationic peptides. Peptides. 20:1999;1265-1273.
28. Giacometti A., Cirioni O., Greganti G., Quarta M., Scalise G. In vitro activities of membrane-active peptides against Gram-positive and Gram-negative aerobic bacteria. Antimicrob. Agents Chemother. 42:1998;3320-3324.
29. Hafez I.M., Maurer N., Cullis P.R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8:2001;1188-1196.
30. Hancock R.E.W. Peptide antibiotics. Lancet. 349:1997;418-422.
31. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1999;1317-1323.
32. Hancock R.E.W., Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:1998;82-88.
33. Hancock R.E.W., Rozek A. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:2002;143-149.
34. 1H nuclear magnetic resonance study of the solution conformation of an antibacterial protein, sapecin FEBS Lett. 269:1990;413-420.
35. Hara T., Kodama H., Kondo M., Wakamatsu K., Takeda A., Tachi T.et al. Effects of peptide dimerization on pore formation: antiparallel disulfide-dimerized magainin 2 analogue. Biopolymers. 58:2001;437-446.
36. Hemmi H., Ishibashi J., Hara S., Yamakawa M. Solution structure of moricin, an antibacterial peptide, isolated from the silkworm Bombyx mori. FEBS Lett. 518:2002;33-38.
37. Hill C.P., Yee J., Selsted M.E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science. 251:1991;1481-1485.
38. Hirakura Y., Kobayashi S., Matsuzaki K. Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides. Biochim. Biophys. Acta. 1562:2002;32-36.
39. Hong R.W., Shchepetov M., Weiser J.N., Axelsen P.H. Transcriptional profile of the Escherichia coli response to the antimicrobial insect peptide cecropin A. Antimicrob. Agents Chemother. 47:2003;1-6.
40. Hoover D.M., Chertov O., Lubkowski J. The structure of human beta-defensin-1: new insights into structural properties of beta-defensins. J. Biol. Chem. 276:2001;39021-39026.
41. Hunter H.N., Fulton D.B., Ganz T., Vogel H.J. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J. Biol. Chem. 277:2002;37597-37603.
42. Hwang P.M., Vogel H.J. Structure-function relationships of antimicrobial peptides. Biochem. Cell. Biol. 76:1998;235-246.
43. Hwang P.M., Zhou N., Shan X., Arrowsmith C.H., Vogel H.J. Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. Biochemistry. 37:1998;4288-4298.
44. Johnstone S.A., Gelmon K., Mayer L.D., Hancock R.E.W., Bally M.B. In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines. Anticancer Drug Des. 15:2000;151-160.
45. Juretic D., Chen H.C., Brown J.H., Morell J.L., Hendler R.W., Westerhoff H.V. Magainin 2 amide and analogues. Antimicrobial activity, membrane depolarization and susceptibility to proteolysis. FEBS Lett. 249:1989;219-223.
46. Juretic D., Hendler R.W., Kamp F., Caughey W.S., Zasloff M., Westerhoff H.V. Magainin oligomers reversibly dissipate delta microH+ in cytochrome oxidase liposomes. Biochemistry. 33:1994;4562-4570.
47. Kawano K., Yoneya T., Miyata T., Yoshikawa K., Tokunaga F., Terada Y.et al. Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus). NMR determination of the beta-sheet structure. J. Biol. Chem. 265:1990;15365-15367.
48. Koradi R, Billeter M, Wuthrich K. MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 1996;14(51-55):29-32.
49. Kragol G., Lovas S., Varadi G., Condie B.A., Hoffmann R., Otvos L. Jr. The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry. 40:2001;3016-3026.
50. Kurz M., Guba W. 3D structure of ramoplanin: a potent inhibitor of bacterial cell wall synthesis. Biochemistry. 35:1996;12570-12575.
51. Laederach A., Andreotti A.H., Fulton D.B. Solution and micelle-bound structures of tachyplesin I and its active aromatic linear derivatives. Biochemistry. 41:2002;12359-12368.
52. Lamberty M., Caille A., Landon C., Tassin-Moindrot S., Hetru C., Bulet P.et al. Solution structures of the antifungal heliomicin and a selected variant with both antibacterial and antifungal activities. Biochemistry. 40:2001;11995-12003.
53. Landon C., Sodano P., Hetru C., Hoffmann J., Ptak M. Solution structure of drosomycin, the first inducible antifungal protein from insects. Protein Sci. 6:1997;1878-1884.
54. Lehrer R.I., Barton A., Daher K.A., Harwig S.S., Ganz T., Selsted M.E. Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J. Clin. Invest. 84:1989;553-561.
55. Mandard N., Bulet P., Caille A., Daffre S., Vovelle F. The solution structure of gomesin, an antimicrobial cysteine-rich peptide from the spider. Eur. J. Biochem. 269:2002;1190-1198.
56. Mandard N., Sodano P., Labbe H., Bonmatin J.M., Bulet P., Hetru C.et al. Solution structure of thanatin, a potent bactericidal and fungicidal insect peptide, determined from proton two-dimensional nuclear magnetic resonance data. Eur. J. Biochem. 256:1998;404-410.
57. Mandard N., Sy D., Maufrais C., Bonmatin J.M., Bulet P., Hetru C.et al. Androctonin, a novel antimicrobial peptide from scorpion Androctonus australis: solution structure and molecular dynamics simulations in the presence of a lipid monolayer. J. Biomol. Struct. Dyn. 17:1999;367-380.
58. 1H NMR study of the solution structure of Ac-AMP2, a sugar binding antimicrobial protein isolated from Amaranthus caudatus J. Mol. Biol. 258:1996;322-333.
59. Masuda M., Nakashima H., Ueda T., Naba H., Ikoma R., Otaka A.et al. A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II). Biochem. Biophys. Res. Commun. 189:1992;845-850.
60. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta. 1376:1998;391-400.
61. Matsuzaki K., Harada M., Funakoshi S., Fujii N., Miyajima K. Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim. Biophys. Acta. 1063:1991;162-170.
62. Matsuzaki K., Harada M., Handa T., Funakoshi S., Fujii N., Yajima H.et al. Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim. Biophys. Acta. 981:1989;130-134.
63. Matsuzaki K., Murase O., Fujii N., Miyajima K. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry. 34:1995;6521-6526.
64. Matsuzaki K., Murase O., Miyajima K. Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry. 34:1995;12553-12559.
65. Matsuzaki K., Nakayama M., Fukui M., Otaka A., Funakoshi S., Fujii N.et al. Role of disulfide linkages in tachyplesin-lipid interactions. Biochemistry. 32:1993;11704-11710.
66. Matsuzaki K., Sugishita K., Harada M., Fujii N., Miyajima K. Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta. 1327:1997;119-130.
67. Matsuzaki K., Yoneyama S., Fujii N., Miyajima K., Yamada K., Kirino Y.et al. Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry. 36:1997;9799-9806.
68. McManus A.M., Dawson N.F., Wade J.D., Carrington L.E., Winzor D.J., Craik D.J. Three-dimensional structure of RK-1: a novel alpha-defensin peptide. Biochemistry. 39:2000;15757-15764.
69. Mohammad F.V., Noorwala M., Ahmad V.U., Sener B. Bidesmosidic triterpenoidal saponins from the roots of Symphytum officinale. Planta Med. 61:1995;94.
70. Morimoto M., Mori H., Otake T., Ueba N., Kunita N., Niwa M.et al. Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro. Chemotherapy. 37:1991;206-211.
71. Murakami T., Niwa M., Tokunaga F., Miyata T., Iwanaga S. Direct virus inactivation of tachyplesin I and its isopeptides from horseshoe crab hemocytes. Chemotherapy. 37:1991;327-334.
72. Nakamura T., Furunaka H., Miyata T., Tokunaga F., Muta T., Iwanaga S.et al. Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem. 263:1988;16709-16713.
73. Oh D., Shin S.Y., Kang J.H., Hahm K.S., Kim K.L., Kim Y. NMR structural characterization of cecropin A(1-8)-magainin 2(1-12) and cecropin A (1-8)-melittin (1-12) hybrid peptides. J. Pept. Res. 53:1999;578-589.
74. Oh D., Shin S.Y., Lee S., Kang J.H., Kim S.D., Ryu P.D.et al. Role of the hinge region and the tryptophan residue in the synthetic antimicrobial peptides, cecropin A(1-8)-magainin 2(1-12) and its analogues, on their antibiotic activities and structures. Biochemistry. 39:2000;11855-11864.
75. Oren Z., Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 47:1998;451-463.
76. Park C.B., Kim H.S., Kim S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244:1998;253-257.
77. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc. Natl. Acad. Sci. U.S.A. 97:2000;8245-8250.
78. Patrzykat A., Friedrich C.L., Zhang L., Mendoza V., Hancock R.E.W. Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli. Antimicrob. Agents Chemother. 46:2002;605-614.
79. Pouny Y., Rapaport D., Mor A., Nicolas P., Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry. 31:1992;12416-12423.
80. Rao A.G. Conformation and antimicrobial activity of linear derivatives of tachyplesin lacking disulfide bonds. Arch. Biochem. Biophys. 361:1999;127-134.
81. Rietveld A.G., Koorengevel M.C., de Kruijff B. Non-bilayer lipids are required for efficient protein transport across the plasma membrane of Escherichia coli. EMBO J. 14:1995;5506-5513.
82. Rozek A., Friedrich C.L., Hancock R.E.W. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry. 39:2000;15765-15774.
83. Sawai M.V., Waring A.J., Kearney W.R., McCray P.B. Jr., Forsyth W.R., Lehrer R.I.et al. Impact of single-residue mutations on the structure and function of ovispirin/novispirin antimicrobial peptides. Protein Eng. 15:2002;225-232.
84. Schibli D.J., Hunter H.N., Aseyev V., Starner T.D., Wiencek J.M., McCray P.B. Jr.et al. The solution structures of the human beta-defensins lead to a better understanding of the potent bactericidal activity of HBD3 against Staphylococcus aureus. J. Biol. Chem. 277:2002;8279-8289.
85. Schibli D.J., Hwang P.M., Vogel H.J. Structure of the antimicrobial peptide tritrpticin bound to micelles: a distinct membrane-bound peptide fold. Biochemistry. 38:1999;16749-16755.
86. Selsted M.E., Novotny M.J., Morris W.L., Tang Y.Q., Smith W., Cullor J.S. Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 267:1992;4292-4295.
87. Shai Y. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:1999;55-70.
88. Subbalakshmi C., Sitaram N. Mechanism of antimicrobial action of indolicidin. FEMS Microbiol. Lett. 160:1998;91-96.
89. Tack B.F., Sawai M.V., Kearney W.R., Robertson A.D., Sherman M.A., Wang W.et al. SMAP-29 has two LPS-binding sites and a central hinge. Eur. J. Biochem. 269:2002;1181-1189.
90. Tamamura H., Ikoma R., Niwa M., Funakoshi S., Murakami T., Fujii N. Antimicrobial activity and conformation of tachyplesin I and its analogs. Chem. Pharm. Bull. (Tokyo). 41:1993;978-980.
91. Tinoco L.W., Da Silva A. Jr., Leite A., Valente A.P., Almeida F.C. NMR structure of PW2 bound to SDS micelles. A tryptophan-rich anticoccidial peptide selected from phage display libraries. J. Biol. Chem. 277:2002;36351-36356.
92. Trabi M., Schirra H.J., Craik D.J. Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. Biochemistry. 40:2001;4211-4221.
93. Wade D., Boman A., Wahlin B., Drain C.M., Andreu D., Boman H.G.et al. All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl. Acad. Sci. U.S.A. 87:1990;4761-4765.
94. Wang Y., Henz M.E., Gallagher N.L., Chai S., Gibbs A.C., Yan L.Z.et al. Solution structure of carnobacteriocin B2 and implications for structure-activity relationships among type IIa bacteriocins from lactic acid bacteria. Biochemistry. 38:1999;15438-15447.
95. Wu M., Maier E., Benz R., Hancock R.E.W. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 38:1999;7235-7242.
96. Yang Y.S., Mitta G., Chavanieu A., Calas B., Sanchez J.F., Roch P.et al. Solution structure and activity of the synthetic four-disulfide bond Mediterranean mussel defensin (MGD-1). Biochemistry. 39:2000;14436-14447.
97. Yonezawa A., Kuwahara J., Fujii N., Sugiura Y. Binding of tachyplesin I to DNA revealed by footprinting analysis: significant contribution of secondary structure to DNA binding and implication for biological action. Biochemistry. 31:1992;2998-3004.
98. Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. U.S.A. 84:1987;5449-5453.
99. Zasloff M., Martin B., Chen H.C. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc. Natl. Acad. Sci. U.S.A. 85:1988;910-913.
100. Zhang L., Benz R., Hancock R.E.W. Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry. 38:1999;8102-8111.
101. Zhang L., Rozek A., Hancock R.E.W. Interaction of cationic antimicrobial peptides with model membranes. J. Biol. Chem. 276:2001;35714-35722.
102. Zimmermann G.R., Legault P., Selsted M.E., Pardi A. Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. Biochemistry. 34:1995;13663-13671.